When a doctor recommends a PET scan or a nuclear medicine test, many patients are unfamiliar with what it involves, why it has been requested, and what to expect. Nuclear medicine is a specialist field that uses small amounts of radioactive material to produce detailed images of how organs and tissues are functioning inside the body – going beyond what standard X-ray, CT, or MRI can show.
Nuclear medicine in India for Sri Lankan patients offers access to advanced diagnostic imaging and targeted treatment technologies that are not widely available in Sri Lanka, at internationally accredited hospitals with specialist teams experienced in oncology, cardiology, neurology, and endocrinology applications.
This guide explains what nuclear medicine is, what the main procedures involve, and how Sri Lankan patients can access these services at Amrita Hospitals.
What Is Nuclear Medicine?
Nuclear medicine is a medical specialty that uses radioactive tracers – called radiopharmaceuticals – to diagnose and in some cases treat medical conditions. These tracers are introduced into the body, typically by injection, and travel to specific organs or tissues where they emit small amounts of radiation detectable by specialised imaging cameras.
The key distinction between nuclear medicine imaging and conventional radiology is this:
- Conventional imaging (X-ray, CT, MRI) shows the structure and anatomy of the body – what things look like
- Nuclear medicine imaging shows the function and metabolism of the body – how things are working
This functional information is particularly valuable in oncology, cardiology, and neurology, where functional changes in tissue often precede visible structural changes – meaning nuclear medicine can detect disease earlier or more accurately than structural imaging alone in many situations.
What Is a PET Scan and What Is It Used For?
A PET scan – Positron Emission Tomography – is the most widely used nuclear medicine imaging procedure. It uses a radioactive tracer, most commonly a form of glucose labelled with a radioactive fluorine atom (FDG – fluorodeoxyglucose), to measure metabolic activity in tissues throughout the body.
Cancer cells consume glucose at a significantly higher rate than normal cells. When FDG is injected, it accumulates in areas of high metabolic activity – most notably in active cancer deposits – which appear as bright spots on the PET image.
What Is a PET-CT Scan?
In clinical practice, PET is almost always combined with CT scanning in a single procedure called a PET-CT scan. The CT component provides detailed anatomical information about where in the body the metabolic activity is occurring. The PET and CT images are fused together, giving the reporting specialist both functional and structural information simultaneously.
What Are PET Scans Used For?
In Oncology
- Initial staging of newly diagnosed cancers – determining how far the cancer has spread, which directly guides treatment planning
- Assessing treatment response – comparing scans before and after chemotherapy or radiation therapy
- Detecting cancer recurrence after treatment
- Identifying the primary source of a cancer when secondary deposits have been found but the origin is unclear
- Guiding biopsy to the most metabolically active part of a tumour
In Cardiology
- Myocardial viability assessment – determining whether areas of the heart muscle that appear damaged are still viable and likely to recover function after revascularisation
In Neurology
- Evaluation of dementia – PET imaging using specific tracers can detect amyloid plaques associated with Alzheimer’s disease before structural changes appear on MRI
- Pre-surgical epilepsy evaluation – PET can identify the seizure focus between seizures as an area of reduced metabolic activity
- Assessment of brain tumour recurrence versus treatment-related changes
For Sri Lankan patients who have been diagnosed with cancer and need staging or treatment response assessment, our article on cancer treatment in India for Sri Lankan patients explains how these investigations fit within the broader oncology pathway at Amrita Hospitals.
What Is a SPECT Scan and How Is It Different from a PET Scan?
A SPECT scan – Single Photon Emission Computed Tomography – is another nuclear medicine imaging technique that creates three-dimensional functional images of the body. Like PET, it uses radioactive tracers, but the tracers and detection technology differ.
Key Differences Between PET and SPECT
- Resolution – PET generally provides higher image resolution than SPECT, making it more sensitive for detecting small lesions
- Tracers – SPECT uses different radioactive tracers, many of which target specific organ systems or receptor types
- Availability – SPECT equipment is more widely available than PET scanners
- Applications – SPECT is particularly well-established in cardiac, bone, thyroid, and brain imaging
Common SPECT Applications
Myocardial Perfusion Imaging (MPI) One of the most frequently performed SPECT procedures. A cardiac-specific tracer is injected and images are acquired at rest and after stress. The scan shows blood flow patterns through the heart muscle, identifying areas of reduced perfusion that indicate coronary artery disease or previous heart attack.
Bone Scintigraphy (Bone Scan) Widely used in oncology to detect bone metastases from primary cancers including breast, prostate, lung, and thyroid cancer. A radioactive tracer that accumulates in areas of increased bone activity is injected, and images are acquired several hours later.
Thyroid Scintigraphy Used to assess thyroid nodules, differentiated thyroid cancer, and thyroid function. Radioactive iodine – which is naturally taken up by thyroid tissue – is used as the tracer.
Brain SPECT Used in epilepsy evaluation, assessment of cerebrovascular disease, and evaluation of movement disorders including Parkinson’s disease (DaTscan).
Renal Scintigraphy Assesses kidney function, drainage, and the relative contribution of each kidney – useful in the evaluation of kidney conditions and pre-operative assessment before kidney surgery.
What Other Nuclear Medicine Procedures Are Available?
Radioiodine Therapy (I-131)
Radioactive iodine is used therapeutically for:
- Hyperthyroidism – radioiodine ablates overactive thyroid tissue, reducing thyroid hormone production. A well-established non-surgical treatment for Graves’ disease and toxic nodular goitre
- Differentiated thyroid cancer – after surgical removal of the thyroid, radioiodine ablation is used to destroy remaining thyroid tissue and treat thyroid cancer metastases
Lutetium-177 DOTATATE Therapy (PRRT)
Peptide receptor radionuclide therapy – a targeted treatment for neuroendocrine tumours (NETs). A radioactive molecule is attached to a peptide that binds specifically to receptors on neuroendocrine tumour cells, delivering targeted radiation directly to the tumour.
Lutetium-177 PSMA Therapy
A theranostic treatment for metastatic prostate cancer. A radioactive molecule targeting PSMA – a protein highly expressed on prostate cancer cells – delivers targeted radiation to prostate cancer deposits throughout the body.
Sentinel Lymph Node Biopsy
A surgical procedure guided by nuclear medicine, used in breast cancer and melanoma surgery to identify the first lymph node draining from a tumour site, allowing assessment of lymph node spread without removing all regional nodes.
How Is Nuclear Medicine Used in Cancer Diagnosis and Treatment?
Nuclear medicine plays a central role across multiple stages of the cancer pathway:
Diagnosis and Initial Staging
PET-CT is the standard staging investigation for many cancers including lymphoma, lung cancer, oesophageal cancer, and head and neck cancers. Accurate staging directly determines the treatment approach.
Treatment Planning
The metabolic information provided by PET-CT guides radiation therapy planning. Areas of high metabolic activity within a tumour can be targeted with higher radiation doses, while lower-activity areas receive standard doses.
Treatment Response Assessment
Comparing PET-CT scans before and after chemotherapy allows oncologists to assess whether treatment is achieving the desired metabolic response, guiding decisions about continuing, changing, or intensifying treatment.
Surveillance and Recurrence Detection
Following completion of treatment, PET-CT is used for surveillance in certain cancers. It can detect metabolically active recurrent disease at an earlier stage than clinical examination or CT alone.
What Is Theranostics?
Theranostics is an emerging concept in nuclear medicine that combines the words therapeutics and diagnostics. It refers to the use of the same molecular target for both imaging and treatment.
The clearest current example is the PSMA theranostic approach in prostate cancer:
- A PSMA-targeted tracer is first used for PET imaging (PSMA PET-CT) to confirm that the patient’s cancer expresses PSMA receptors and to map the extent of disease
- If imaging confirms suitability, the same molecular target is used for therapy using Lutetium-177 PSMA, delivering targeted radiation directly to the cancer deposits
This approach allows treatment decisions to be made based on the molecular characteristics of the individual patient’s cancer – a principle that aligns closely with the broader movement toward precision oncology.
How Should a Patient Prepare for a Nuclear Medicine Scan?
Preparation varies depending on the type of scan:
For FDG PET-CT
- Fasting for 4 to 6 hours before the scan is required, as eating raises blood glucose levels which reduces the contrast between normal tissue and cancer deposits
- Diabetic patients require specific preparation protocols to manage blood sugar appropriately before scanning
- Strenuous exercise should be avoided for 24 hours before the scan
- The radiotracer is injected approximately 60 minutes before imaging begins
- The scan itself takes approximately 20 to 30 minutes in the scanner
- Patients are advised to stay well hydrated and avoid close contact with pregnant women and young children for a few hours after the scan
For Myocardial Perfusion SPECT
- Certain cardiac medications may need to be held before the stress component of the scan
- Caffeine must be avoided for 24 to 48 hours if pharmacological stress is being used
- Fasting for 4 hours before the scan is typically required
For Bone Scan
- No specific fasting required
- Images are acquired several hours after tracer injection
- Good hydration and frequent urination in the interval between injection and imaging helps reduce background radiation and improve image quality
For Thyroid Scintigraphy and Radioiodine Therapy
- A low-iodine diet for 1 to 2 weeks before the procedure is required
- Thyroid medications may need to be stopped under specialist supervision
Is Nuclear Medicine Safe?
Nuclear medicine procedures use small amounts of radioactive material. The radiation doses involved are carefully calculated to be the minimum necessary to obtain diagnostic quality images or achieve the therapeutic effect.
Key safety points:
- The radiation dose from a diagnostic nuclear medicine scan is comparable to, or in many cases lower than, the dose from a CT scan
- The radioactive tracers used have short half-lives and are cleared from the body within hours to days
- Allergic reactions to nuclear medicine tracers are rare
- Nuclear medicine procedures are not recommended during pregnancy
- Breastfeeding mothers may need to temporarily pause breastfeeding after certain procedures
The risk-benefit balance of nuclear medicine procedures is assessed individually. In most clinical situations where a nuclear medicine scan is recommended, the diagnostic information it provides significantly outweighs the minimal radiation risk involved.
Why Do Sri Lankan Patients Choose India for Nuclear Medicine?
- Advanced nuclear medicine infrastructure at Amrita Hospitals including PET-CT, SPECT-CT, and theranostic treatment capability – technology that is limited in availability in Sri Lanka
- Integration with oncology and cardiology teams – nuclear medicine results are reviewed within a multidisciplinary clinical framework, ensuring imaging findings are immediately applied to treatment planning
- Theranostic programme including Lutetium-177 PSMA therapy for prostate cancer and PRRT for neuroendocrine tumours – advanced treatments not widely available in South Asia
- Same-day or rapid reporting – important for patients travelling from Sri Lanka who need results before returning home
- Geographic proximity to Sri Lanka – reducing the burden of travel for what may be a short diagnostic visit
For patients undergoing cancer treatment who require PET-CT as part of staging or response assessment, our article on cancer treatment in India for Sri Lankan patients provides context on how nuclear medicine integrates into the broader oncology pathway.
To explore the full range of diagnostic and treatment services available, visit advanced diagnostics and treatment in India for Sri Lankan patients.
How Do Sri Lankan Patients Access Nuclear Medicine in India?
- Confirm the specific nuclear medicine procedure requested by your doctor in Sri Lanka and gather your existing imaging reports and clinical letters
- Share these with Amrita Info Centre Sri Lanka for forwarding to the relevant specialist team at Amrita Hospitals
- Receive confirmation of appointment availability and specific preparation requirements for your procedure
- Apply for your medical visa – nuclear medicine procedures are included under the medical visa category
- Travel to Amrita Hospitals for your scan or treatment
For many nuclear medicine diagnostic procedures, the total time required in India may be as short as one to two days. Amrita Info Centre Sri Lanka can advise on the expected duration for your specific procedure.
For full guidance on the visa application process, our article on the Complete Guide to Medical Visa for India from Sri Lanka covers documentation requirements and application steps in detail.
For patients also managing travel and accommodation around a short diagnostic visit, patient travel and accommodation assistance is available through Amrita Info Centre Sri Lanka.
Frequently Asked Questions
What is the difference between a PET scan and a CT scan? A CT scan uses X-rays to produce detailed images of the body’s structure and anatomy. A PET scan uses a radioactive tracer to show how tissues are functioning metabolically. Combined as a PET-CT scan, both structural and functional information is provided simultaneously – making it significantly more informative than either scan alone for cancer staging and assessment.
Will I be radioactive after a nuclear medicine scan? Yes, briefly. After a diagnostic nuclear medicine scan, small amounts of radioactive tracer remain in the body while it clears naturally. The radioactivity is minimal and reduces rapidly. Patients are advised to avoid prolonged close contact with pregnant women and young children for a few hours after the procedure.
How long does a PET-CT scan take? The total time from tracer injection to completion of imaging is typically 2 to 3 hours. The actual time in the scanner is approximately 20 to 30 minutes. Patients rest quietly after injection while the tracer distributes before entering the scanner.
Can I drive after a nuclear medicine scan? Most diagnostic nuclear medicine procedures do not affect driving ability. If sedation has been administered, patients should not drive until the following day.
Does my existing CT or MRI from Sri Lanka need to be repeated in India? Not necessarily. Bringing your existing imaging on a CD or digital format allows the team at Amrita Hospitals to review it before your appointment, which may reduce the need for repeat imaging and helps ensure your nuclear medicine scan is appropriately tailored to the clinical question being answered.
Is nuclear medicine used for treatment as well as diagnosis? Yes. Radioiodine therapy for thyroid conditions, Lutetium-177 PSMA therapy for prostate cancer, and PRRT for neuroendocrine tumours are all nuclear medicine treatments that deliver targeted radiation directly to specific tissues or cancer cells.
Conclusion
Nuclear medicine in India for Sri Lankan patients provides access to advanced diagnostic imaging and targeted treatment technologies – from PET-CT cancer staging and myocardial perfusion assessment to cutting-edge theranostic treatments for prostate cancer and neuroendocrine tumours – that are not widely available in Sri Lanka.
For patients who have been referred for a PET scan, SPECT study, radioiodine therapy, or any nuclear medicine procedure, Amrita Info Centre Sri Lanka can coordinate the appointment, preparation guidance, and travel logistics – ensuring the process from referral to report is as smooth as possible.